Botox lawsuit raises issues on injections

A federal lawsuit filed in California by Las Vegas physician Ivan Goldsmith argues that sales representatives for Allergan Inc., maker of the popular anti-wrinkle drug Botox, promote multipatient use of its 50-unit or 100-unit single-use vials.

Goldsmith’s lawsuit alleges that doctors can only make a profit using Botox if they reuse the single-use vials that the drug comes in.

Read full story via ReviewJournal.com.

Short URL: http://www.plasticsurgeonsnews.com/?p=462

Posted by admin on Oct 18 2009. Filed under Injectables, Laser Procedures, Marketing, News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry